# FDA Inspection 1072997 - Biomat USA, Inc. - October 18, 2018

Source: https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/d3f996af-7926-4101-8f2a-671c8986e5ea
Source feed: FDA_Inspections

> FDA Inspection 1072997 for Biomat USA, Inc. on October 18, 2018. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1072997
- Company Name: Biomat USA, Inc.
- Inspection Date: 2018-10-18
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1171129 - 2022-05-23](https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/b2d7bf45-6af4-4335-a632-db7551d4a8cc)
- [FDA Inspection 1171129 - 2022-05-23](https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/58f9966f-a5eb-47be-8dc6-daf399553089)
- [FDA Inspection 956205 - 2016-01-27](https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/ce67ad3d-add1-4e9f-9606-98112018e944)
- [FDA Inspection 940370 - 2015-08-27](https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/8b039354-2c47-4bd8-9167-49d3dfc06ceb)
- [FDA Inspection 741254 - 2011-08-19](https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/15f5c6c2-0eba-47a0-bbe7-09fe84ebabd1)

Company: https://www.keypedia.com/companies/biomat-usa-inc/2ba0407b-16af-42df-8089-5c92ad99c8fc

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d
